Home > News > Biopharmaceutical Midday Gainers: QGLY, BPAX, NXXI - sourced PicksThatMove.com
August 18th, 2009
Biopharmaceutical Midday Gainers: QGLY, BPAX, NXXI - sourced PicksThatMove.com
Abstract:
Biosante Pharmaceuticals, Inc. (NGM: BPAX) maintained its gain of 15.82% by midday to rise to $2.27 (the company was up 25% in pre-trading) on news clinical trials show that it's booster adjuvant bio-enhances and increases the efficacy of vaccines, including new vaccines for H1N1. Based in Lincolnshire, Illinois, Biosante Pharmaceuticals is a biopharmaceutical company developing hormone therapy products to treat men and women. It also develops proprietary nanotechnology. The company also produces aesthetic derma filers, BioVant for the treatment of viral and bacterial infections and autoimmune diseases, as well as inhalable applications for protein and therapy administration.
Source:
transworldnews.com
Bookmark:
| Related Links |
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||